Off the wire
• Nigeria to camp athletes ahead of IAAF World Youth Championships  • 1st LD: Sudanese president spotted outside S. African hotel: report  • Roundup: Afghan forces kill over 90 militants, president reviews security situation  • Chinese officials look to ancient classics for leadership arts  • Urgent: Sudanese president spotted outside S. African hotel: report  • China's largest crowdsourcer raises record funds  • Mt. Qomolangma moves 40 cm northeastward in 10 years  • Sudanese President spotted outside hotel in South Africa: local media  • Yemen consultations convene in Geneva to end crisis  • Roundup: Singapore stocks end down 0.92 pct  
You are here: 　 Home

China, U.S. develop new MERS treatment

Xinhua, June 15, 2015 Adjust font size:

Chinese and American scientists have jointly developed a new antibody targeting the Middle East Respiratory Syndrome (MERS) virus, which has killed 16 people and landed 150 others in hospital.

Fudan University, which worked with U.S. National Institutes of Health to develop the antibody, said on Monday that tests on animals had seen "very effective" results.

Jiang Shibo, who led the research team at Fudan, said the m336 antibody could neutralize MERS virus more effectively than other antibodies.

Zhong Nanshan, a renowned respiratory expert, called for an immediate clinical trial.

The m336 antibody treatment has proved more effective when coupled with a specific type of polypeptide, according to Jiang. Endi